Skip to content
Search

Latest Stories

NHSE&I reinstates flu vaccination service training for pharmacists

The NHS England and NHS Improvement, working with Public Health England, has confirmed that the normal training requirements for pharmacists providing the service are being reinstated for the 2021/22 season.

The Pharmaceutical Services Negotiating Committee (PSNC) has received several queries from community pharmacy contractors on the training requirements for the NHS Seasonal Influenza Vaccination Advanced Service (Flu Vaccination Service) 2021/22.


Pharmacists providing the Flu vaccination Service need to attend face-to-face training for both injection technique and basic life support (including administration of adrenaline for anaphylaxis) training at least every three years. 

In addition to the face-to-face training, within the last two years pharmacists must have completed and signed the Vaccination Services Declaration of Competence (DoC).

Pharmacists are also expected to undertake annual update training each year, to ensure their knowledge stays up to date with changes in practice and guidance. This may involve self-directed learning, using relevant references sources, such as the Green Book and the annual flu letter. It may also include online training which is available from a range of providers.

To support the provision of the service in the 2020/21 season and as part of measures to support pharmacy operations during the pandemic, NHSE&I previously agreed that pharmacists who had undertaken vaccination training in 2017 and were due to repeat face-to-face in 2020 did not need to do this until 2021. 

The requirement for pharmacists to undertake this training on a three-yearly basis is now reinstated. Vaccination services DoC last completed in 2019, 2020, and 2021 must be completed again in 2021, 2022, and 2023 respectively.

Pharmacists can start to work through the Vaccination Services DoC self-assessment framework and complete the learning, training, and assessment to fill any gaps identified. However, the service documents such as the service specification and Patient Group Direction (PGD) for the 2021/22 service are not available yet. Pharmacists will need to read, understand, and sign these documents before they sign their statement of declaration for the Vaccination Services DoC.

Pharmacists are also reminded that if they signed the Vaccination Services DoC last year or during a previous year, they would have declared that they meet or were actively working towards the Consultation Skills for Pharmacy Practice: Practice Standards for England, as determined by Health Education England.

If pharmacists confirmed that they were actively working towards the standards, they declared that they were undertaking the relevant learning and CPD to meet the standards. It is expected that pharmacists will have accessed the standards and associated learning to meet this requirement and that pharmacists should have completed the assessment within 12 months of signing the vaccination Services DoC statement of declaration.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less